Ligand Pharmaceuticals
LGND
A$206.79
Share price
-0.67%
Change (1 day)
24.58%
Change (1 year)
EPS for Ligand Pharmaceuticals (LGND)
EPS in 2025 (TTM): A-$11.06
According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$10.91. In 2024 the company made an earnings per share (EPS) of A-$0.07663 a decrease over its 2023 EPS that were of A$4.43.
EPS history for Ligand Pharmaceuticals from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | A-$11.06 | 14327.39% |
| 2024 | A-$0.07663 | -101.73% |
| 2023 | A$4.43 | -245.96% |
| 2022 | A-$3.03 | -157.23% |
| 2021 | A$5.30 | -2571.43% |
| 2020 | A-$0.21 | -100.46% |
| 2019 | A$46.92 | 353.48% |
| 2018 | A$10.35 | 1025% |
| 2017 | A$0.92 | -700% |
| 2016 | A-$0.15 | -100.87% |
| 2015 | A$17.72 | 1859.32% |
| 2014 | A$0.90 | 5.36% |
| 2013 | A$0.86 | 8.0704505322479E+18% |
| 2012 | A$0.0000000000 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | A$16.94 | -255.20% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | A-$0.55 | -94.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | A$2.39 | -121.91% | 🇬🇧 UK |
 Merck MRK | A$10.57 | -196.87% | 🇺🇸 USA |
 Pfizer PFE | A$2.13 | -119.52% | 🇺🇸 USA |
 Eli Lilly LLY | A$18.94 | -273.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | A$4.11 | -137.64% | 🇺🇸 USA |
 Baxter BAX | A-$0.04598 | -99.58% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$13.90 | -227.35% | 🇺🇸 USA |